These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2517762)

  • 1. Treatment of pathologic emotionality with thyrotropin-releasing hormone.
    Komurasaki Y; Yokoyama T; Ogura J; Maeda K
    Jpn J Psychiatry Neurol; 1989 Dec; 43(4):665-8. PubMed ID: 2517762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of TRH-T for spinocerebellar degeneration--the relation between clinical features and effect of TRH therapy].
    Waragai M; Ogawara K; Takaya Y; Hayashi M
    Rinsho Shinkeigaku; 1997 Jul; 37(7):587-94. PubMed ID: 9396355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic experimentation with TRH administered intramuscularly in spinocerebellar degeneration. Double-blind cross-over study in 30 subjects].
    Filla A; De Michele G; Di Martino L; Mengano A; Iorio L; Maggio MA; Campanella G
    Riv Neurol; 1989; 59(2):83-8. PubMed ID: 2505370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of thyrotropin-releasing hormone on neurologic recovery and biogenic amine metabolites of cerebrospinal fluid in spinal disorders].
    Hirofuji E; Tanaka S
    Nihon Seikeigeka Gakkai Zasshi; 1989 Nov; 63(11):1306-15. PubMed ID: 2515232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic laughing and crying treated with levodopa.
    Udaka F; Yamao S; Nagata H; Nakamura S; Kameyama M
    Arch Neurol; 1984 Oct; 41(10):1095-6. PubMed ID: 6477219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical application of thyrotropin-releasing hormone to neurogenic bladder caused by olivo-ponto-cerebellar atrophy].
    Murayama K; Katsumi T
    Hinyokika Kiyo; 1985 Mar; 31(3):495-8. PubMed ID: 3927664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ; Utiger RD
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P300 and cerebral blood flow before and after TRH in olivopontocerebellar atrophy.
    Mochizuki Y; Oishi M; Hara M; Takasu T
    Int J Neurosci; 1997 Nov; 92(1-2):119-26. PubMed ID: 9522261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Olivopontocerebellar atrophy as an important differential diagnosis in atactic gait disorders in elderly patients].
    Waespe W; Hayek J; Wichmann W; Bader JP
    Schweiz Med Wochenschr; 1988 Jul; 118(27-28):1032-8. PubMed ID: 3166204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of pathologic laughter and crying in patients with locked-in syndrome: a report of 4 cases.
    Sacco S; Sarà M; Pistoia F; Conson M; Albertini G; Carolei A
    Arch Phys Med Rehabil; 2008 Apr; 89(4):775-8. PubMed ID: 18374012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Madopar in the treatment of paralysis agitans: II. TRH activation test, EMG examination and HVA level in cerebrospinal fluid before and after treatment].
    Liu DK
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Apr; 13(4):223-6. PubMed ID: 6790255
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy of nasal bi-level positive airway pressure ventilation in a patient with olivo-ponto-cerebellar atrophy suffering from sleep apnea syndrome].
    Iijima M; Ota K; Ubano M; Kikuchi M; Iwata M
    Rinsho Shinkeigaku; 1997 Jun; 37(6):492-6. PubMed ID: 9366176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electromyographic study of facial expressions during pathological laughing and crying.
    Tanaka M; Sumitsuji N
    Electromyogr Clin Neurophysiol; 1991; 31(7):399-406. PubMed ID: 1748077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of thyrotropin-releasing hormone (TRH) on cerebral blood flow in spinocerebellar degeneration and cerebrovascular disease.
    Izumi Y; Fukuuchi Y; Ishihara N; Imai A; Komatsumoto S
    Tokai J Exp Clin Med; 1995 Dec; 20(4-6):203-8. PubMed ID: 8956461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of the thyrotropin-releasing hormone (TRH) analogue, taltireline hydrate, in spinal muscular atrophy.
    Kato Z; Okuda M; Okumura Y; Arai T; Teramoto T; Nishimura M; Kaneko H; Kondo N
    J Child Neurol; 2009 Aug; 24(8):1010-2. PubMed ID: 19666885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rhythmical involuntary movement at rest associated with olivo-ponto-cerebellar atrophy (OPCA)].
    Noda K; Isozaki E; Miyamoto K; Hirose K; Tanabe H; Oda M
    Rinsho Shinkeigaku; 1993 Jan; 33(1):8-14. PubMed ID: 8334781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between mood and TSH response to TRH stimulation in bipolar affective disorder.
    Larsen JK; Faber J; Christensen EM; Bendsen BB; Solstad K; Gjerris A; Siersbaek-Nielsen K
    Psychoneuroendocrinology; 2004 Aug; 29(7):917-24. PubMed ID: 15177707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of thyrotropin-releasing hormone and thyrotropin reserve in man.
    Singer PA; Nicoloff JT
    J Clin Invest; 1973 May; 52(5):1099-107. PubMed ID: 4633675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
    Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
    Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.